Recombinant Hamster I-309/CCL1 Protein, N- His & GST

I-309, also known as CCL1 (chemokine (C-C motif) ligand 1), is a chemokine that is increasingly recognized for its role in immune response and inflammation. This small protein is primarily involved in the recruitment and activation of lymphocytes, particularly T cells and eosinophils, to sites of inflammation. The study of I-309/CCL1 has gained traction due to its potential implications in various diseases, including asthma, allergies, and autoimmune disorders, where enhanced immune responses contribute to pathology. Research has focused on understanding its signaling mechanisms and biological functions, particularly through its interaction with the CCR8 receptor, which is predominantly expressed on Th2 cells and regulatory T cells. Moreover, the therapeutic potential of targeting the I-309/CCL1 axis has been explored in the context of modulating immune responses, offering avenues for novel treatments in inflammatory and allergic diseases. Recombinant I-309/CCL1 proteins have been utilized in studies to elucidate their role in chemotaxis, cell signaling, and to explore their utility in therapeutic applications such as vaccine development and anti-inflammatory strategies. The ongoing research into this chemokine highlights its significance in the broader context of immunology and its promise as a target for innovative therapeutic interventions.